The earnings call for Enovis was generally positive, with strong revenue and margin growth, successful product launches, and improved financial guidance. However, there were challenges such as delays in the Arvis product launch, flat growth in the U.S. hip and knee segment, and tariff-related headwinds. Despite these setbacks, the company's overall performance and outlook are optimistic.

Company Guidance

During Enovis' second-quarter 2025 earnings call, the company announced several key financial metrics and provided updated guidance. Enovis reported a 7% increase in sales to $565 million, with organic growth of 5%. Their Recon business achieved 8% organic growth, while P&R grew by 3%. Adjusted gross margins expanded by 90 basis points in the quarter, with a 200 basis point improvement year-to-date. Adjusted EBITDA was flat at 17.2%, with year-to-date expansion of 75 basis points. The company raised its revenue guidance to a range of $2.245 billion to $2.275 billion, driven by improved currency outlooks and strong organic growth execution. Organic growth guidance was increased to 6.25% to 6.75%, and adjusted earnings per share guidance was increased by $0.10 to a range of $3.05 to $3.20. Enovis also reiterated its expectation for positive free cash flow in 2025, with a focus on reducing debt and improving leverage.

Strong Revenue Growth

Enovis delivered reported growth of 7% and 5% on an organic constant currency basis in the second quarter of 2025. Recon business saw organic growth of 8%, and the company's revenue guidance for the year was raised by $25 million.

Improvements in Margin and Earnings

Adjusted gross margins improved by 90 basis points in the quarter and 200 basis points year-to-date. Adjusted earnings per share increased by 27% versus the prior year.

Positive Developments in Product Launches

The company reported good progress on new product launches, with the Nebula system and OrthoDrive surgical impactor receiving positive feedback from surgeons.

Successful Integration of Acquisitions

The integration of Lima has unlocked growth potential, particularly in the shoulder segment, with ARG and SMR systems driving competitive share gains.

Raised Financial Guidance

Enovis increased its revenue guidance by $25 million and raised its adjusted EBITDA range by $7 million, reflecting improved currency outlook and organic growth execution.

Enovis (ENOV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ENOV Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	0.65 / -	0.73	―	―	―
Aug 07, 2025	2025 (Q2)	0.72 / 0.79	0.62	27.42% (+0.17)
May 08, 2025	2025 (Q1)	0.74 / 0.81	0.5	62.00% (+0.31)
Feb 26, 2025	2024 (Q4)	0.92 / 0.98	0.79	24.05% (+0.19)
Nov 06, 2024	2024 (Q3)	0.62 / 0.73	0.56	30.36% (+0.17)
Aug 07, 2024	2024 (Q2)	0.59 / 0.62	0.61	1.64% (+0.01)
May 02, 2024	2024 (Q1)	0.48 / 0.50	0.44	13.64% (+0.06)
Feb 22, 2024	2023 (Q4)	0.74 / 0.79	0.72	9.72% (+0.07)
Nov 07, 2023	2023 (Q3)	0.54 / 0.56	0.59	-5.08% (-0.03)
Aug 03, 2023	2023 (Q2)	0.53 / 0.61	0.59	3.39% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ENOV Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$25.76	$28.52	+10.71%
May 08, 2025	$34.24	$33.08	-3.39%
Feb 26, 2025	$42.10	$40.00	-4.99%
Nov 06, 2024	$43.31	$46.90	+8.29%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Enovis (ENOV) report earnings?

Enovis (ENOV) is schdueled to report earning on Oct 30, 2025, TBA (Confirmed).

What is Enovis (ENOV) earnings time?

Enovis (ENOV) earnings time is at Oct 30, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ENOV EPS forecast?

ENOV EPS forecast for the fiscal quarter 2025 (Q3) is 0.65.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing